https://scholars.lib.ntu.edu.tw/handle/123456789/637314
標題: | Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial | 作者: | LI-MIN HUANG Schibler, Andreas Huang, Yi-Chuan Tai, Andrew Chi, Hsin Chieng, Chae-Hee Wang, Jinn-Li Goldbart, Aviv Tang, Swee-Ping Huang, Yhu-Chering George, Shane Alabaz, Derya Bentur, Lea Su, Siew-Choo de Bruyne, Jessie Karadag, Bulent Gu, Feng Zou, Gang Toovey, Stephen DeVincenzo, John P Wu, Jim Z |
關鍵字: | AK0529; fusion inhibitor; infants; respiratory syncytial virus (RSV); ziresovir | 公開日期: | 七月-2023 | 卷: | 17 | 期: | 7 | 來源出版物: | Influenza and other respiratory viruses | 摘要: | Respiratory syncytial virus (RSV) infection is a cause of substantial morbidity and mortality in young children. There is currently no effective therapy available. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/637314 | ISSN: | 17502640 | DOI: | 10.1111/irv.13176 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。